Jeremiah Robinson
Medical · Atlanta, GANPI 1073970240
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 70.2% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $13,627, 5.3 times the $2,562 reported in 2021. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $75.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$16K
- Napo Pharmaceuticals Inc$3K
- Viiv Healthcare Company$800
- Novo Nordisk$261
- Endo Pharmaceuticals Inc.$237
- Lilly USA, LLC$235
- plus $2K from 27 others
What the payments were for
- Consulting fees$1,3406%
- Speaking & faculty fees$12,96157%
- Travel & lodging$2,58111%
- Food & beverage$5,92026%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 86 | $16,039 |
| Napo Pharmaceuticals Inc | 10 | $3,168 |
| Viiv Healthcare Company | 42 | $800 |
| Novo Nordisk | 18 | $261 |
| Endo Pharmaceuticals Inc. | 12 | $237 |
| Lilly USA, LLC | 16 | $235 |
| Otsuka America Pharmaceutical, Inc. | 9 | $183 |
| Eisai Inc. | 12 | $164 |
| Merz North America, Inc. | 3 | $152 |
| Johnson & Johnson(2 entities) | 7 | $148 |
| Theratechnologies Inc. | 9 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| Paratek Pharmaceuticals, Inc. | 7 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $126 |
| AbbVie | 7 | $100 |
| Merck | 5 | $77 |
| Esperion Therapeutics, Inc. | 5 | $75 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Antares Pharma, Inc. | 5 | $72 |
| Abbott | 4 | $67 |
| GSK | 3 | $54 |
| Pfizer | 3 | $54 |
| Lundbeck LLC | 2 | $46 |
| Clarus Therapeutics Inc. | 3 | $42 |
| Vyera Pharmaceuticals, LLC | 2 | $40 |
| Nabriva Therapeutics, PLC | 2 | $39 |
| Acerus Pharmaceuticals Corporation | 3 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Janssen Products, LP | 1 | $30 |
| Aytu Biopharma, Inc. | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,832 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
- Katherine QuinleyAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.